These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 24357334)
1. Retinal vasoproliferative tumors in 6 patients with neurofibromatosis type 1. Shields JA; Pellegrini M; Kaliki S; Mashayekhi A; Shields CL JAMA Ophthalmol; 2014 Feb; 132(2):190-6. PubMed ID: 24357334 [TBL] [Abstract][Full Text] [Related]
2. Iris neovascularization and neovascular glaucoma in neurofibromatosis type 1: report of 3 cases in children. Al Freihi SH; Edward DP; Nowilaty SR; Abouammoh MA; Morales J J Glaucoma; 2013; 22(4):336-41. PubMed ID: 22138687 [TBL] [Abstract][Full Text] [Related]
3. Retinal metastasis from systemic cancer in 8 cases. Shields CL; McMahon JF; Atalay HT; Hasanreisoglu M; Shields JA JAMA Ophthalmol; 2014 Nov; 132(11):1303-8. PubMed ID: 25033168 [TBL] [Abstract][Full Text] [Related]
4. Retinal vasoproliferative tumors: comparative clinical features of primary vs secondary tumors in 334 cases. Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Shukla SY; Reilly B; Shields JA JAMA Ophthalmol; 2013 Mar; 131(3):328-34. PubMed ID: 23494037 [TBL] [Abstract][Full Text] [Related]
5. Neovascular glaucoma in a pediatric patient with neurofibromatosis type 1: a case report. Liu S; Ran L; Qi D; Meng X; Yu T BMC Ophthalmol; 2020 Apr; 20(1):168. PubMed ID: 32345252 [TBL] [Abstract][Full Text] [Related]
6. Cryotherapy-induced release of epiretinal membrane associated with retinal vasoproliferative tumor: analysis of 16 cases. Manjandavida FP; Shields CL; Kaliki S; Shields JA Retina; 2014 Aug; 34(8):1644-50. PubMed ID: 24752009 [TBL] [Abstract][Full Text] [Related]
8. Clinical features and treatment outcomes of vasoproliferative tumors in Indian participants. Walinjkar JA; Sharma US; Rishi P; Rishi E; Gopal L; Sharma T Indian J Ophthalmol; 2018 Feb; 66(2):246-251. PubMed ID: 29380768 [TBL] [Abstract][Full Text] [Related]
9. [Vasoproliferative tumor associated with presumed ocular tuberculosis: case report]. Rodrigues LD; Serracarbassa LL; Rosa H; Nakashima Y; Serracarbassa PD Arq Bras Oftalmol; 2007; 70(3):527-31. PubMed ID: 17768565 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration]. Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687 [TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors. Saito W; Kase S; Fujiya A; Dong Z; Noda K; Ishida S Retina; 2013 Oct; 33(9):1959-67. PubMed ID: 23652580 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and clinical course of ocular ischemic syndrome with retinal vascular abnormalities due to unilateral ocular artery and internal carotid artery stenosis in a child with neurofibromatosis type 1: a case report. Sakai H; Kawata K; Masuoka J; Nishimura T; Enaida H BMC Ophthalmol; 2020 Oct; 20(1):426. PubMed ID: 33097012 [TBL] [Abstract][Full Text] [Related]